The updates on Middle East Respiratory Syndrome coronavirus (MERS-CoV) epidemiology, pathogenesis, viral genome and currently available drugs

Abstract

References

1. Mailles, A.; Blanckaert, K.; Chaud, P.; Van der Werf, S.; Lina, B.; Caro, V.; Campese, C.; Guéry, B.; Prouvost, H.; Lemaire, X., First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Euro Surveill 2013, 12, 19-23 DOI: https://doi.org/10.2807/ese.18.24.20502-en
3. Organization, W. H., Middle East respiratory syndrome coronavirus (MERS-CoV)–update. Saudi Med J 2014, 35 (6), 633-634.
5. Zaki, A. M.; Van Boheemen, S.; Bestebroer, T. M.; Osterhaus, A. D.; Fouchier, R. A., Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New Eng J Med 2012, 367 (19), 1814-1820.
6. https://doi.org/10.1056/NEJMoa1211721 DOI: https://doi.org/10.1056/NEJMoa1211721
8. Assiri, A.; McGeer, A.; Perl, T. M.; Price, C. S.; Al Rabeeah, A. A.; Cummings, D. A.; Alabdullatif, Z. N.; Assad, M.; Almulhim, A.; Makhdoom, H., Hospital outbreak of Middle East respiratory syndrome coronavirus. New Eng J Med 2013, 369 (5), 407-416.
9. https://doi.org/10.1056/NEJMoa1306742 DOI: https://doi.org/10.1056/NEJMoa1306742
11. Hui, D. S.; Perlman, S.; Zumla, A., Spread of MERS to South Korea and China. The Lancet Respir Med 2015, 3 (7), 509-510
12. https://doi.org/10.1016/S2213-2600(15)00238-6 DOI: https://doi.org/10.1016/S2213-2600(15)00238-6
14. Memish, Z. A.; Almasri, M.; Turkestani, A.; Al-Shangiti, A. M.; Yezli, S., Etiology of severe community-acquired pneumonia during the 2013 Hajj—part of the MERS-CoV surveillance program. Int J Infect Dis 2014, 25, 186-190.
15. https://doi.org/10.1016/j.ijid.2014.06.003 DOI: https://doi.org/10.1016/j.ijid.2014.06.003
17. Control, C. F. D.; Prevention, CDC Health Information for International Travel 2016. Oxford University Press: 2015.
19. Chan, J. F.; Lau, S. K.; To, K. K.; Cheng, V. C.; Woo, P. C.; Yuen, K.-Y., Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 2015, 28 (2), 465-522.
20. https://doi.org/10.1128/CMR.00102-14 DOI: https://doi.org/10.1128/CMR.00102-14
22. Adney, D. R.; van Doremalen, N.; Brown, V. R.; Bushmaker, T.; Scott, D.; de Wit, E.; Bowen, R. A.; Munster, V. J., Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels. Emerg Infect Dis 2014, 20 (12), 1999-2005.
23. https://doi.org/10.3201/eid2012.141280 DOI: https://doi.org/10.3201/eid2012.141280
25. Memish, Z. A.; Cotten, M.; Meyer, B.; Watson, S. J.; Alsahafi, A. J.; Al Rabeeah, A. A.; Corman, V. M.; Sieberg, A.; Makhdoom, H. Q.; Assiri, A., Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis 2014, 20 (6), 1012-1015.
26. https://doi.org/10.3201/eid2006.140402 DOI: https://doi.org/10.3201/eid2006.140402
28. Haagmans, B. L.; Al Dhahiry, S. H.; Reusken, C. B.; Raj, V. S.; Galiano, M.; Myers, R.; Godeke, G.-J.; Jonges, M.; Farag, E.; Diab, A., Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. The Lancet Infect Dis 2014, 14 (2), 140-145.
29. https://doi.org/10.1016/S1473-3099(13)70690-X DOI: https://doi.org/10.1016/S1473-3099(13)70690-X
31. Goh, G. K.-M.; Dunker, A. K.; Uversky, V., Prediction of intrinsic disorder in MERS-CoV/HCoV-EMC supports a high oral-fecal transmission. PLoS Curr 2013, Nov 13, Edition 1. DOI: https://doi.org/10.1371/currents.outbreaks.22254b58675cdebc256dbe3c5aa6498b
33. Cauchemez, S.; Van Kerkhove, M.; Riley, S.; Donnelly, C.; Fraser, C.; Ferguson, N., Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill 2013, 18 (24), 20503. DOI: https://doi.org/10.2807/ese.18.24.20503-en
35. Gardner, L. M.; MacIntyre, C. R., Unanswered questions about the Middle East respiratory syndrome coronavirus (MERS-CoV). BMC Res Notes 2014, 7 (358), 1-5.
36. https://doi.org/10.1186/1756-0500-7-358 DOI: https://doi.org/10.1186/1756-0500-7-358
38. Banik, G.; Khandaker, G.; Rashid, H., Middle East Respiratory Syndrome Coronavirus "MERS-CoV": Current Knowledge Gaps. Paedtr Respir Rev 2015, 16(3), 197-202.
39. https://doi.org/10.1016/j.prrv.2015.04.002 DOI: https://doi.org/10.1016/j.prrv.2015.04.002
41. Assiri, A.; Al-Tawfiq, J. A.; Al-Rabeeah, A. A.; Al-Rabiah, F. A.; Al-Hajjar, S.; Al-Barrak, A.; Flemban, H.; Al-Nassir, W. N.; Balkhy, H. H.; Al-Hakeem, R. F., Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. The Lancet Infect Dis 2013, 13 (9), 752-761.
42. https://doi.org/10.1016/S1473-3099(13)70204-4 DOI: https://doi.org/10.1016/S1473-3099(13)70204-4
44. Guery, B.; Poissy, J.; el Mansouf, L.; Séjourné, C.; Ettahar, N.; Lemaire, X.; Vuotto, F.; Goffard, A.; Behillil, S.; Enouf, V., Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. The Lancet 2013, 381 (9885), 2265-2272.
45. https://doi.org/10.1016/S0140-6736(13)60982-4 DOI: https://doi.org/10.1016/S0140-6736(13)60982-4
47. Sharif-Yakan, A.; Kanj, S. S., Emergence of MERS-CoV in the Middle East: origins, transmission, treatment, and perspectives. PLoS Pathog 2014, 10 (12), e1004457.
48. https://doi.org/10.1371/journal.ppat.1004457 DOI: https://doi.org/10.1371/journal.ppat.1004457
50. Momattin, H.; Mohammed, K.; Zumla, A.; Memish, Z. A.; Al-Tawfiq, J. A., Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)–possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis 2013, 17 (10), e792-e798.
51. https://doi.org/10.1016/j.ijid.2013.07.002 DOI: https://doi.org/10.1016/j.ijid.2013.07.002
53. Mackay, I. M.; Arden, K. E., Middle East respiratory syndrome: An emerging coronavirus infection tracked by the crowd. Virus Res 2015, 202, 60-88.
54. https://doi.org/10.1016/j.virusres.2015.01.021 DOI: https://doi.org/10.1016/j.virusres.2015.01.021
56. Breban, R.; Riou, J.; Fontanet, A., Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. The Lancet 2013, 382 (9893), 694-699.
57. https://doi.org/10.1016/S0140-6736(13)61492-0 DOI: https://doi.org/10.1016/S0140-6736(13)61492-0
59. Al-Tawfiq, J. A.; Zumla, A.; Memish, Z. A., Travel implications of emerging coronaviruses: SARS and MERS-CoV. Trav Med Infect Dis 2014, 12 (5), 422-428.
60. https://doi.org/10.1016/j.tmaid.2014.06.007 DOI: https://doi.org/10.1016/j.tmaid.2014.06.007
62. Corman, V.; Eckerle, I.; Bleicker, T.; Zaki, A.; Landt, O.; Eschbach-Bludau, M.; Van Boheemen, S.; Gopal, R.; Ballhause, M.; Bestebroer, T., Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Euro Surveill 2013, 12, 30-35. DOI: https://doi.org/10.2807/ese.17.39.20285-en
64. Omrani, A. S.; Matin, M. A.; Haddad, Q.; Al-Nakhli, D.; Memish, Z. A.; Albarrak, A. M., A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int J Infect Dis 2013, 17 (9), e668-e672.
65. https://doi.org/10.1016/j.ijid.2013.07.001 DOI: https://doi.org/10.1016/j.ijid.2013.07.001
67. Skowronski, D. M.; Astel, C.; Brunham R. C.; Low, D. E.; Petric, M.; Roper, R. L.; Talbot, P. J.; Babiuk, L. Severe Acute Respiratory Syndrome (SARS): a year in review. Annu Rev Med 2005, 56, 357-381.
68. https://doi.org/10.1146/annurev.med.56.091103.134135 DOI: https://doi.org/10.1146/annurev.med.56.091103.134135
70. Shrivastava, A.; Srikantiah, P.; Kumar, A. et al., Outbreaks of Unexplained Neurologic Illness—Muzaffarpur, India, 2013–2014. MMWR Morb Mortal Wkly Rep 2015, 64 (3), 49-76.
72. Cauchemez, S.; Fraser, C.; Van Kerkhove, M. D.; Donnelly, C. A.; Riley, S.; Rambaut, A.; Enouf, V.; van der Werf, S.; Ferguson, N. M., Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. The Lancet Infect Dis 2014, 14 (1), 50-56.
73. https://doi.org/10.1016/S1473-3099(13)70304-9 DOI: https://doi.org/10.1016/S1473-3099(13)70304-9
75. Petersen, E.; Hui, D. S.; Perlman, S.; Zumla, A., Middle East Respiratory Syndrome–advancing the public health and research agenda on MERS-lessons from the South Korea outbreak. Int J Infect Dis 2015, 36, 54-55.
76. https://doi.org/10.1016/j.ijid.2015.06.004 DOI: https://doi.org/10.1016/j.ijid.2015.06.004
78. Su, S.; Wong, G.; Liu, Y.; Gao, G. F.; Li, S.; Bi, Y., MERS in South Korea and China: a potential outbreak threat? The Lancet 2015, 385 (9985), 2349-2350.
79. https://doi.org/10.1016/S0140-6736(15)60859-5 DOI: https://doi.org/10.1016/S0140-6736(15)60859-5
81. Sudre, B., Public health issue. 2015.
83. De Wit, E.; Rasmussen, A. L.; Falzarano, D.; Bushmaker, T.; Feldmann, F.; Brining, D. L.; Fischer, E. R.; Martellaro, C.; Okumura, A.; Chang, J., Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci 2013, 110 (41), 16598-16603.
84. https://doi.org/10.1073/pnas.1310744110 DOI: https://doi.org/10.1073/pnas.1310744110
86. Wang, N.; Shi, X.; Jiang, L.; Zhang, S.; Wang, D.; Tong, P.; Guo, D.; Fu, L.; Cui, Y.; Liu, X., Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res 2013, 23 (8), 986-993.
87. https://doi.org/10.1038/cr.2013.92 DOI: https://doi.org/10.1038/cr.2013.92
89. Raj, V. S.; Mou, H.; Smits, S. L.; Dekkers, D. H.; Müller, M. A.; Dijkman, R.; Muth, D.; Demmers, J. A.; Zaki, A.; Fouchier, R. A., Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013, 495 (7440), 251-254.
90. https://doi.org/10.1038/nature12005 DOI: https://doi.org/10.1038/nature12005
92. Van Doremalen, N.; Miazgowicz, K. L.; Milne-Price, S.; Bushmaker, T.; Robertson, S.; Scott, D.; Kinne, J.; McLellan, J. S.; Zhu, J.; Munster, V. J., Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4. J Virol 2014, 88 (16), 9220-9232.
93. https://doi.org/10.1128/JVI.00676-14 DOI: https://doi.org/10.1128/JVI.00676-14
95. Falzarano, D.; de Wit, E.; Feldmann, F.; Rasmussen, A. L.; Okumura, A.; Peng, X.; Thomas, M. J.; van Doremalen, N.; Haddock, E.; Nagy, L., Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLos Pathog, 2014, 10 (8), e1004250.
96. https://doi.org/10.1371/journal.ppat.1004250 DOI: https://doi.org/10.1371/journal.ppat.1004250
98. Schnittler, H.; Feldmann, H., Molecular pathogenesis of filovirus infections: role of macrophages and endothelial cells. Curr Top Microbiol Immunol 1999, 235, 175-204.
99. https://doi.org/10.1007/978-3-642-59949-1_10 DOI: https://doi.org/10.1007/978-3-642-59949-1_10
101. Hutchinson, K. L.; Villinger, F.; Miranda, M. E.; Ksiazek, T. G.; Peters, C.; Rollin, P. E., Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (reston serotype). J Med Virol 2001, 65 (3), 561-566.
102. https://doi.org/10.1002/jmv.2073 DOI: https://doi.org/10.1002/jmv.2073
104. Fisher-Hoch, S.; McCormick, J., Pathophysiology and treatment of Lassa fever. In Arenaviruses, Springer 1987, 231-239.
105. https://doi.org/10.1007/978-3-642-71726-0_10 DOI: https://doi.org/10.1007/978-3-642-71726-0_10
107. Kumar, A.; Sharma, N.; Singh, S.; Sasmal, D.; Dev, A., Oral vaccine antigen induced immune response signalling pathways: current and future perspectives. J Vaccines Vaccin 2014, 5, 2-6.
109. Kumar, A.; Sasmal, D.; Sharma, N., Understanding of complex signaling pathways of immune system: A Review. World J Pharm Pharm Sci 2014, 3 (10), 241-255
111. Yang, Y.; Zhang, L.; Geng, H.; Deng, Y.; Huang, B.; Guo, Y.; Zhao, Z.; Tan, W., The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein & Cell 2013, 4 (12), 951-961.
112. https://doi.org/10.1007/s13238-013-3096-8 DOI: https://doi.org/10.1007/s13238-013-3096-8
114. Faure, E.; Poissy, J.; Goffard, A.; Fournier, C.; Kipnis, E.; Titecat, M.; Bortolotti, P.; Martinez, L.; Dubucquoi, S.; Dessein, R., Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside. PLoS One 2014, 9 (2), e88716.
115. https://doi.org/10.1371/journal.pone.0088716 DOI: https://doi.org/10.1371/journal.pone.0088716
117. Chu, H.; Zhou, J.; Wong, B. H.-Y.; Li, C.; Cheng, Z.-S.; Lin, X.; Poon, V. K.-M.; Sun, T.; Lau, C. C.-Y.; Chan, J. F.-W., Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology 2014, 454, 197-205.
118. https://doi.org/10.1016/j.virol.2014.02.018 DOI: https://doi.org/10.1016/j.virol.2014.02.018
120. Banchereau, J.; Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998, 392 (6673), 245-252.
121. https://doi.org/10.1038/32588 DOI: https://doi.org/10.1038/32588
123. Josset, L.; Menachery, V. D.; Gralinski, L. E.; Agnihothram, S.; Sova, P.; Carter, V. S.; Yount, B. L.; Graham, R. L.; Baric, R. S.; Katze, M. G., Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. MBio 2013, 4 (3), e00165-13.
124. https://doi.org/10.1128/mBio.00165-13 DOI: https://doi.org/10.1128/mBio.00165-13
126. Scobey, T.; Yount, B. L.; Sims, A. C.; Donaldson, E. F.; Agnihothram, S. S.; Menachery, V. D.; Graham, R. L.; Swanstrom, J.; Bove, P. F.; Kim, J. D., Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc Natl Acad Sci 2013, 110 (40), 16157-16162.
127. https://doi.org/10.1073/pnas.1311542110 DOI: https://doi.org/10.1073/pnas.1311542110
129. Nowotny, N.; Kolodziejek, J., Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013. Euro Surveill 2014, 19 (16), 20781.
130. https://doi.org/10.2807/1560-7917.ES2014.19.16.20781 DOI: https://doi.org/10.2807/1560-7917.ES2014.19.16.20781
132. Lee, H.; Lei, H.; Santarsiero, B. D.; Gatuz, J. L.; Cao, S.; Rice, A. J.; Patel, K.; Szypulinski, M. Z.; Ojeda, I.; Ghosh, A. K., Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. ACS Chem Biol 2015. 10(6), 1456-1465.
133. https://doi.org/10.1021/cb500917m DOI: https://doi.org/10.1021/cb500917m
135. Needle, D.; Lountos, G.; Waugh, D., Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity. Acta Crystallogr D 2015, 71 (5), 1102-1111.
136. https://doi.org/10.1107/S1399004715003521 DOI: https://doi.org/10.1107/S1399004715003521
138. Bailey-Elkin, B. A.; Knaap, R. C.; Johnson, G. G.; Dalebout, T. J.; Ninaber, D. K.; van Kasteren, P. B.; Bredenbeek, P. J.; Snijder, E. J.; Kikkert, M.; Mark, B. L., Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression. J Biol Chem 2014, 289 (50), 34667-34682.
139. https://doi.org/10.1074/jbc.M114.609644 DOI: https://doi.org/10.1074/jbc.M114.609644
141. Lei, J.; Mesters, J. R.; Drosten, C.; Anemüller, S.; Ma, Q.; Hilgenfeld, R., Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features. Antiviral Res 2014, 109, 72-82.
142. https://doi.org/10.1016/j.antiviral.2014.06.011
144. Dyall, J.; Coleman, C. M.; Venkataraman, T.; Holbrook, M. R.; Kindrachuk, J.; Johnson, R. F.; Olinger, G. G.; Jahrling, P. B.; Laidlaw, M.; Johansen, L. M., Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother 2014, 58 (8), 4885-4893.
145. https://doi.org/10.1128/AAC.03036-14 DOI: https://doi.org/10.1128/AAC.03036-14
147. Pohjala, L.; Utt, A.; Varjak, M.; Lulla, A.; Merits, A.; Ahola, T.; Tammela, P., Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One 2011, 6 (12), e28923.
148. https://doi.org/10.1371/journal.pone.0028923 DOI: https://doi.org/10.1371/journal.pone.0028923
150. De Wilde, A. H.; Jochmans, D.; Posthuma, C. C.; Zevenhoven-Dobbe, J. C.; van Nieuwkoop, S.; Bestebroer, T. M.; van den Hoogen, B. G.; Neyts, J.; Snijder, E. J., Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother 2014, 58 (8), 4875-4884.
151. https://doi.org/10.1128/AAC.03011-14 DOI: https://doi.org/10.1128/AAC.03011-14
153. Adedeji, A. O.; Singh, K.; Kassim, A.; Coleman, C. M.; Elliott, R.; Weiss, S. R.; Frieman, M. B.; Sarafianos, S. G., Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Middle East Respiratory Syndrome Coronaviruses. Antimicrob Agents Chemother 2014, 58 (8), 4894-4898.
154. https://doi.org/10.1128/AAC.02994-14 DOI: https://doi.org/10.1128/AAC.02994-14
156. Omrani, A. S.; Saad, M. M.; Baig, K.; Bahloul, A.; Abdul-Matin, M.; Alaidaroos, A. Y.; Almakhlafi, G. A.; Albarrak, M. M.; Memish, Z. A.; Albarrak, A. M., Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. The Lancet Infect Dis 2014, 14 (11), 1090-1095.
157. https://doi.org/10.1016/S1473-3099(14)70920-X DOI: https://doi.org/10.1016/S1473-3099(14)70920-X
159. Dyall, J.; Postnikova, E.; Zhou, H.; Kindrachuk, J.; Johnson, R. F.; Olinger, G. G.; Frieman, M. B.; Holbrook, M. R.; Jahrling, P. B.; Hensley, L., Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. J Gen Virol 2014, 95 (3), 571-577. DOI: https://doi.org/10.1099/vir.0.061911-0
161. Chan, J. F.; Chan, K.-H.; Kao, R. Y.; To, K. K.; Zheng, B.-J.; Li, C. P.; Li, P. T.; Dai, J.; Mok, F. K.; Chen, H., Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect 2013, 67 (6), 606-616.
162. https://doi.org/10.1016/j.jinf.2013.09.029 DOI: https://doi.org/10.1016/j.jinf.2013.09.029
164. Briolant, S.; Garin, D.; Scaramozzino, N.; Jouan, A.; Crance, J., In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-α and ribavirin combination. Antiviral Res 2004, 61 (2), 111-117.
165. https://doi.org/10.1016/j.antiviral.2003.09.005 DOI: https://doi.org/10.1016/j.antiviral.2003.09.005
167. Lei, J.; Mesters, J. R.; Drosten, C.; Anemüller, S.; Ma, Q.; Hilgenfeld, R., Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features. Antiviral Res 2014, 109, 72-82.
168. https://doi.org/10.1016/j.antiviral.2014.06.011 DOI: https://doi.org/10.1016/j.antiviral.2014.06.011
170. Ma, C.; Wang, L.; Tao, X.; Zhang, N.; Yang, Y.; Tseng, C.-T. K.; Li, F.; Zhou, Y.; Jiang, S.; Du, L., Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments—the importance of immunofocusing in subunit vaccine design. Vaccine 2014, 32 (46), 6170-6176.
171. https://doi.org/10.1016/j.vaccine.2014.08.086 DOI: https://doi.org/10.1016/j.vaccine.2014.08.086
173. Coleman, C. M.; Liu, Y. V.; Mu, H.; Taylor, J. K.; Massare, M.; Flyer, D. C.; Glenn, G. M.; Smith, G. E.; Frieman, M. B., Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine 2014, 32 (26), 3169-3174.
174. https://doi.org/10.1016/j.vaccine.2014.04.016 DOI: https://doi.org/10.1016/j.vaccine.2014.04.016

Author information

• Surender Singh Jadav

  Biral Institute of Technology, Mesra

• Narayana Murthy Ganta

  Biral Institute of Technology, Mesra

  Bio

• Anoop Kumar

  Biral Institute of Technology, Mesra

  Bio

• Nirnoy Dan

  Birla Institute of Technology, Mesra ROR

  Bio

• Neha Padma Mohanty

  Odisha University of Agriculture and Technology, Bhubaneswar

  Bio

Rights and permissions

About this article

Received

August 10, 2015

Published

April 30, 2016

Issue

Vol. 3 No. 2 (2016)

Section

Research Reviews

Pages

10-18

Keywords

• Virus
• Medicinal Chemistry
• Replication
• Inhibitors